SFS
SNOA icon

Sowell Financial Services’s Sonoma Pharmaceuticals SNOA Stock Holding History

Sowell Financial Services’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1
Closed – – 2692
2020
Q2 		$0 Hold
1
– – ﹤0.01% 2650
2020
Q1 		$0 Hold
1
– – ﹤0.01% 2672
2019
Q4 		$0 Hold
1
– – ﹤0.01% 2645
2019
Q3 		$0 Buy
+1
New +$129 ﹤0.01% 2452
2017
Q1 		– Sell
-1
Closed -$1K – 522
2016
Q4 		$1K Buy
+1
New +$829 ﹤0.01% 625

Other funds holding SNOA

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
RE
RBC Europe London, United Kingdom $2.08B AUM 12.2% 1-Year Est. Return

Sowell Financial Services's SNOA Position: Q3 2020 in Review

Sowell Financial Services sold out of Sonoma Pharmaceuticals (SNOA) in Q3 2020, closing a stake of 1 share.

Sowell Financial Services first reported a position in SNOA in Q4 2016 and held it in 5 quarters. The position peaked at $1K in Q4 2016. 18 funds tracked by Wall St. Rank hold SNOA as of Q3 2020.

  • Sowell Financial Services reported no remaining Sonoma Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Sowell Financial Services sold 1 Sonoma Pharmaceuticals share in Q3 2020.
  • Sowell Financial Services first reported a position in Sonoma Pharmaceuticals in Q4 2016 and held it in 5 quarters.
  • Sowell Financial Services's Sonoma Pharmaceuticals position peaked at $1K in Q4 2016.
  • 18 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q3 2020.

Based on Sowell Financial Services's 13F filing for Q3 2020, filed 12 Nov 2020.